chr8:38268656:> Detail (hg19) (FGFR1)
Information
Genome
Assembly | Position |
---|---|
hg19 | chr8:38,268,656-38,326,352 |
hg38 | chr8:38,411,138-38,468,834 |
HGVS
Type | Transcript | Protein |
---|---|---|
Summary
MGeND
Clinical significance | |
Variant entry | |
GWAS entry | |
Disease area statistics | Show details |
Frequency
[No Data.]
Prediction
[No Data.]
ClinVar
Clinical Significance | |
Review star | [No Data.] |
Show details |
Links
Disease area statistics
[No Data.]
MGeND
[No Data.]
ClinVar
[No Data.]
CIViC
[No Data.]
DisGeNET
Score | Disease name | Description | Source | Pubmed | Links |
---|---|---|---|---|---|
0.127 | squamous cell carcinoma | One hundred twelve primary tumors (including squamous cell carcinoma [SCC], carc... | BeFree,CTD_human,LHGDN | 23913758 | Detail |
<0.001 | Carcinoma, Transitional Cell | NA | BeFree | Detail | |
0.080 | Transient ischemic attack | NA | RGD | Detail | |
<0.001 | chondrosarcoma | In the present study, we found that bFGF induced VEGF (vascular endothelial grow... | BeFree | 25735814 | Detail |
<0.001 | chordoma | NA | BeFree | Detail | |
<0.001 | choriocarcinoma | NA | BeFree | Detail | |
0.002 | Chromosome Aberrations | NA | GAD | Detail | |
<0.001 | Congenital chromosomal disease | NA | BeFree | Detail | |
0.130 | cleft lip | NA | CTD_human,GAD,LHGDN | Detail | |
0.128 | cleft palate | NA | BeFree,CTD_human,GAD,LHGDN | Detail | |
<0.001 | cleidocranial dysplasia | Expression of RUNX2 and its signaling partners TCF7, FGFR1/2 in cleidocranial dy... | BeFree | 25738174 | Detail |
0.002 | colorectal carcinoma | Finally we found that cells overexpressing SOX2 in vitro showed enhanced express... | BeFree | 25010701 | Detail |
0.002 | colorectal carcinoma | AZD-4547 was cytotoxic and pro-apoptotic in FGFR-1/2-expressed CRC cell lines (N... | BeFree | 25691251 | Detail |
0.003 | Colorectal Neoplasms | NA | LHGDN | Detail | |
<0.001 | Coronary Arteriosclerosis | The extent of coronary atherosclerosis in this patient set strongly correlated w... | BeFree | 26517696 | Detail |
0.002 | Craniofacial Dysostosis | NA | GAD | Detail | |
0.014 | craniosynostosis | NA | BeFree,GAD,LHGDN | Detail | |
<0.001 | cryptorchidism | NA | BeFree | Detail | |
0.080 | Dementia, Vascular | NA | RGD | Detail | |
<0.001 | Demyelinating Diseases | NA | BeFree | Detail | |
0.120 | depressive disorder | NA | CTD_human | Detail | |
<0.001 | dermatitis | FLG mutations affected the lifetime prevalence of hand and foot dermatitis in pa... | BeFree | 25659224 | Detail |
0.005 | Dermatitis, Atopic | Patients (n = 43) were classified according to their FLG status: AD with FLG+/+ ... | BeFree | 24330146 | Detail |
0.005 | Dermatitis, Atopic | FLG mutations affected the lifetime prevalence of hand and foot dermatitis in pa... | BeFree | 25659224 | Detail |
<0.001 | Diabetes Mellitus, Non-Insulin-Dependent | NA | BeFree | Detail | |
0.007 | Eczema | Patients (n = 43) were classified according to their FLG status: AD with FLG+/+ ... | BeFree | 24330146 | Detail |
0.007 | Eczema | FLG deficiency predisposes to eczema vaccinatum. | BeFree | 25649082 | Detail |
0.007 | Eczema | FLG mutations affected the lifetime prevalence of hand and foot dermatitis in pa... | BeFree | 25659224 | Detail |
<0.001 | endometriosis | Increased expression of fibroblast growth factor receptor 1 in endometriosis and... | BeFree | 25500535 | Detail |
0.002 | Eosinophilia | NA | BeFree | Detail | |
0.008 | glioblastoma | NA | BeFree,LHGDN | Detail | |
0.121 | Glioma | NA | BeFree,CTD_human | Detail | |
<0.001 | goiter | NA | BeFree | Detail | |
<0.001 | Hay fever | NA | BeFree | Detail | |
<0.001 | Sensorineural Hearing Loss (disorder) | NA | BeFree | Detail | |
<0.001 | Hematological Disease | NA | BeFree | Detail | |
<0.001 | Hyperparathyroidism, Secondary | NA | BeFree | Detail | |
0.002 | Immediate hypersensitivity | NA | GAD | Detail | |
0.002 | Hypertensive disease | NA | GAD | Detail | |
0.080 | pulmonary hypertension | NA | BeFree,RGD | Detail | |
0.010 | hypogonadism | NA | GAD,LHGDN | Detail | |
0.002 | Hypothalamic Diseases | NA | GAD | Detail | |
<0.001 | influenza | A Functional Role of Fibroblast Growth Factor Receptor 1 (FGFR1) in the Suppress... | BeFree | 25909503 | Detail |
0.002 | Klinefelter syndrome | A female patient with normosmic idiopathic hypogonadotropic hypogonadism carryin... | BeFree | 25501157 | Detail |
0.002 | Klinefelter syndrome | Novel FGFR1 mutations in Kallmann syndrome and normosmic idiopathic hypogonadotr... | BeFree | 26277103 | Detail |
0.003 | Fibroid Tumor | NA | LHGDN | Detail | |
0.002 | leukemia | Interestingly, unlike the prototypical leukaemia-inducing FGFR1 fusion genes, wh... | BeFree | 25319834 | Detail |
<0.001 | Acute Erythroblastic Leukemia | NA | BeFree | Detail | |
<0.001 | Acute lymphocytic leukemia | NA | BeFree | Detail | |
0.002 | Leukemia, Myelocytic, Acute | NA | BeFree | Detail | |
<0.001 | Myeloid Leukemia, Chronic | NA | BeFree | Detail | |
<0.001 | Leukemia, Myelomonocytic, Chronic | NA | BeFree | Detail | |
<0.001 | acute promyelocytic leukemia | NA | BeFree | Detail | |
<0.001 | Liver neoplasms | NA | BeFree | Detail | |
0.120 | Lung Neoplasms | A tissue microarray composed of resected lung tumors was submitted to FGFR1 GCN,... | BeFree,CTD_human | 24771645 | Detail |
<0.001 | lymphocytic choriomeningitis | NA | BeFree | Detail | |
0.002 | lymphoma | NA | BeFree | Detail | |
<0.001 | Malignant neoplasm of stomach | Identification of gastric cancers harboring FGFR1 amplification may be important... | BeFree | 26239623 | Detail |
0.002 | Marijuana Abuse | NA | GAD | Detail | |
0.004 | melanoma | NA | BeFree,LHGDN | Detail | |
<0.001 | meningioma | NA | BeFree | Detail | |
<0.001 | Mesothelioma | Furthermore, RNAi-mediated silencing confirmed the requirement for FGFR1 in spec... | BeFree | 24966347 | Detail |
<0.001 | Mesothelioma | The aim of this study was to evaluate the amplification of the FGFR1 gene in pat... | BeFree | 25138167 | Detail |
0.080 | Mouth Diseases | NA | RGD | Detail | |
<0.001 | multiple myeloma | NA | BeFree | Detail | |
0.131 | Myeloproliferative disease | NA | BeFree,CTD_human,LHGDN | Detail | |
0.006 | Neoplasm Metastasis | Amplification of the FGFR1 gene is a rare but noticeable event that can be found... | BeFree,LHGDN | 26239623 | Detail |
<0.001 | neuroblastoma | NA | BeFree | Detail | |
0.083 | obesity | NA | BeFree,GAD,RGD | Detail | |
<0.001 | Degenerative polyarthritis | NA | BeFree | Detail | |
<0.001 | osteomalacia | Compared to Hyp mice, compound Hyp;Fgfr1Dmp1-cKO-null mice had significant impro... | BeFree | 25089825 | Detail |
<0.001 | osteosarcoma | FGFR1 amplification is present disproportionately in the rarer histological vari... | BeFree | 24861215 | Detail |
<0.001 | ovarian carcinoma | Both epidermal growth factor receptor (EGFR) and fibroblast growth factor recept... | BeFree | 25919378 | Detail |
<0.001 | paraganglioma | NA | BeFree | Detail | |
0.001 | Pituitary Diseases | NA | BeFree | Detail | |
0.002 | polycystic ovary syndrome | NA | GAD | Detail | |
0.003 | Prostatic Neoplasms | NA | LHGDN | Detail | |
<0.001 | psoriasis | NA | BeFree | Detail | |
0.002 | Psychoses, Substance-Induced | NA | GAD | Detail | |
0.005 | Delayed puberty | NA | GAD,LHGDN | Detail | |
0.002 | Precocious Puberty | NA | GAD | Detail | |
<0.001 | retinal degeneration | NA | BeFree | Detail | |
0.080 | retinal detachment | NA | RGD | Detail | |
<0.001 | retinoblastoma | NA | BeFree | Detail | |
0.003 | rhabdomyosarcoma | NA | BeFree,LHGDN | Detail | |
<0.001 | rickets | Compared to Hyp mice, compound Hyp;Fgfr1Dmp1-cKO-null mice had significant impro... | BeFree | 25089825 | Detail |
0.123 | schizophrenia | NA | BeFree,CTD_human,GAD | Detail | |
0.080 | Seizures | NA | RGD | Detail | |
<0.001 | Dermatologic disorders | NA | BeFree | Detail | |
<0.001 | gastric ulcer | NA | BeFree | Detail | |
<0.001 | syndactyly | NA | BeFree | Detail | |
0.002 | Tobacco use disorder | NA | GAD | Detail | |
<0.001 | Unipolar Depression | NA | BeFree | Detail | |
<0.001 | Virus Diseases | Here, we investigated four members of the fibroblast growth factor receptor (FGF... | BeFree | 25909503 | Detail |
<0.001 | Werner syndrome | NA | BeFree | Detail | |
0.002 | ichthyosis vulgaris | Moisturizing treatment of patients with atopic dermatitis and ichthyosis vulgari... | BeFree | 24330146 | Detail |
<0.001 | Ichthyosis, X-Linked | NA | BeFree | Detail | |
<0.001 | B-Cell Lymphomas | NA | BeFree | Detail | |
0.001 | Precursor cell lymphoblastic lymphoma | NA | BeFree | Detail | |
<0.001 | T-Cell Lymphoma | NA | BeFree | Detail | |
<0.001 | Tooth Loss | NA | BeFree | Detail | |
0.002 | Bronchial Hyperreactivity | NA | GAD | Detail | |
0.002 | Ovarian Failure, Premature | NA | GAD | Detail | |
<0.001 | acute leukemia | NA | BeFree | Detail | |
0.005 | Squamous cell carcinoma of lung | The purpose of this study was to elucidate if these tumors harbor amplifications... | BeFree | 23913758 | Detail |
0.005 | Squamous cell carcinoma of lung | Importantly, only 46% of SCCs with increased FGFR1 GCN expressed high mRNA. | BeFree | 24771645 | Detail |
0.005 | Squamous cell carcinoma of lung | FGFR1 amplification in lung squamous cell carcinoma: a systematic review with me... | BeFree | 25433983 | Detail |
0.121 | Small cell carcinoma of lung | The frequency and impact of FGFR1 amplification on clinical outcomes in Korean p... | BeFree,CTD_human | 25819384 | Detail |
0.080 | sciatic neuropathy | NA | RGD | Detail | |
<0.001 | Dry skin | Moisturizing treatment of patients with atopic dermatitis and ichthyosis vulgari... | BeFree | 24330146 | Detail |
<0.001 | Adenocarcinoma of lung (disorder) | NA | BeFree | Detail | |
<0.001 | Malignant neoplasm of brain | NA | BeFree | Detail | |
<0.001 | Secondary malignant neoplasm of bone | Prostate cancer cell-stromal cell crosstalk via FGFR1 mediates antitumor activit... | BeFree | 25186177 | Detail |
<0.001 | Hearing Loss, Mixed Conductive-Sensorineural | NA | BeFree | Detail | |
<0.001 | allergic asthma | NA | BeFree | Detail | |
<0.001 | Cleft palate with cleft lip | TGFβ, FGA, PDGFc, PDGFRa, FGF, FGFR1, FGFR2 growth factors as well as MMP and TI... | BeFree | 25176321 | Detail |
0.263 | Kallmann syndrome | Childhood growth of females with Kallmann syndrome and FGFR1 mutations. | BeFree,CTD_human,GAD,LHGDN,ORPHANET | 24841555 | Detail |
0.263 | Kallmann syndrome | Mutations in the fibroblast growth factor receptor 1 gene (FGFR1) have been repo... | BeFree,CTD_human,GAD,LHGDN,ORPHANET | 25501157 | Detail |
0.263 | Kallmann syndrome | Novel FGFR1 mutations in Kallmann syndrome and normosmic idiopathic hypogonadotr... | BeFree,CTD_human,GAD,LHGDN,ORPHANET | 26277103 | Detail |
0.001 | Tumor Progression | NA | BeFree | Detail | |
<0.001 | Idiopathic hypereosinophilic syndrome | NA | BeFree | Detail | |
0.080 | Tympanic Membrane Perforation | NA | RGD | Detail | |
<0.001 | alveolar rhabdomyosarcoma | NA | BeFree | Detail | |
<0.001 | embryonal carcinoma | NA | BeFree | Detail | |
<0.001 | Carcinoma, Lobular | NA | BeFree | Detail | |
<0.001 | Carcinoma, Large Cell | NA | BeFree | Detail | |
<0.001 | inverted papilloma | FGFR1 amplification was found in subsets of sinonasal SCCs (20%), carcinomas ass... | BeFree | 23913758 | Detail |
0.120 | gliosarcoma | NA | ORPHANET | Detail | |
<0.001 | uveal melanoma | NA | BeFree | Detail | |
<0.001 | Metastatic malignant neoplasm to brain | NA | BeFree | Detail | |
<0.001 | Synkinesis | NA | BeFree | Detail | |
0.002 | pancreatic carcinoma | NA | BeFree | Detail | |
<0.001 | Gastrointestinal Stromal Tumors | Here, we report that ligands from the FGF family reduced the effectiveness of im... | BeFree | 25673643 | Detail |
<0.001 | panhypopituitarism | NA | BeFree | Detail | |
0.004 | Malignant neoplasm of lung | The aim of this study was to investigate the prevalence of fibroblast growth fac... | BeFree | 24762544 | Detail |
0.004 | Malignant neoplasm of lung | FGFR1 mRNA and protein expression, not gene copy number, predict FGFR TKI sensit... | BeFree | 24771645 | Detail |
0.004 | Malignant neoplasm of lung | FGFR1 activation is an escape mechanism in human lung cancer cells resistant to ... | BeFree | 25115383 | Detail |
0.004 | Malignant neoplasm of lung | Kinome RNAi Screens Reveal Synergistic Targeting of MTOR and FGFR1 Pathways for ... | BeFree | 26359452 | Detail |
<0.001 | Disorder of skeletal system | NA | BeFree | Detail | |
<0.001 | disseminated eosinophilic collagen disease | NA | BeFree | Detail | |
<0.001 | Trigonocephaly | NA | BeFree | Detail | |
<0.001 | Ectrodactyly | NA | BeFree | Detail | |
<0.001 | Congenital clinodactyly | NA | BeFree | Detail | |
<0.001 | Congenital anomaly of face | NA | BeFree | Detail | |
0.007 | hypogonadotropic hypogonadism | A female patient with normosmic idiopathic hypogonadotropic hypogonadism carryin... | BeFree,GAD | 25501157 | Detail |
0.007 | hypogonadotropic hypogonadism | Novel FGFR1 mutations in Kallmann syndrome and normosmic idiopathic hypogonadotr... | BeFree,GAD | 26277103 | Detail |
<0.001 | Carcinoma breast stage IV | NA | BeFree | Detail | |
<0.001 | Breast cancer recurrent | NA | BeFree | Detail | |
<0.001 | gastric adenocarcinoma | Fibroblast growth factor receptor 1 gene amplification in gastric adenocarcinoma... | BeFree | 26239623 | Detail |
<0.001 | Invasive lobular breast carcinoma | NA | BeFree | Detail | |
<0.001 | Squamous cell carcinoma of esophagus | Fibroblast growth factor receptor 1 gene amplification is associated with poor s... | BeFree | 25537505 | Detail |
<0.001 | Solid tumour | The FGFR1 is a therapeutic target under investigation in multiple solid tumors a... | BeFree | 26359452 | Detail |
<0.001 | stage, non-small cell lung cancer | NA | BeFree | Detail | |
<0.001 | diffuse astrocytoma | Pediatric LGG show alterations in FGFR1 and BRAF in pilocytic astrocytomas and F... | BeFree | 25664944 | Detail |
<0.001 | Tumor necrosis | NA | BeFree | Detail | |
0.121 | pilocytic astrocytoma | Pediatric LGG show alterations in FGFR1 and BRAF in pilocytic astrocytomas and F... | BeFree,ORPHANET | 25664944 | Detail |
0.121 | pilocytic astrocytoma | KIAA1549: BRAF Gene Fusion and FGFR1 Hotspot Mutations Are Prognostic Factors in... | BeFree,ORPHANET | 26083571 | Detail |
0.120 | giant cell glioblastoma | NA | ORPHANET | Detail | |
0.121 | Septo-Optic Dysplasia | NA | BeFree,ORPHANET | Detail | |
<0.001 | Hypothalamic amenorrhea | NA | BeFree | Detail | |
0.120 | Idiopathic hypogonadotropic hypogonadism | NA | CTD_human | Detail | |
<0.001 | Human papilloma virus infection | NA | BeFree | Detail | |
<0.001 | chronic eosinophilic leukemia | NA | BeFree | Detail | |
0.002 | Malignant neoplasm of pancreas | NA | BeFree | Detail | |
0.002 | Malignant neoplasm of prostate | NA | BeFree | Detail | |
0.002 | Hematologic Neoplasms | NA | BeFree | Detail | |
0.120 | Craniofacial Abnormalities | NA | CTD_human | Detail | |
<0.001 | Developmental absence of tooth | NA | BeFree | Detail | |
<0.001 | Chronic Kidney Insufficiency | NA | BeFree | Detail | |
<0.001 | Dysmorphic features | NA | BeFree | Detail | |
<0.001 | Secondary malignant neoplasm of liver | Finally we found that cells overexpressing SOX2 in vitro showed enhanced express... | BeFree | 25010701 | Detail |
<0.001 | atopic eczema/dermatitis (non-specific) | NA | BeFree | Detail | |
0.002 | Sleep Apnea, Obstructive | NA | GAD | Detail | |
<0.001 | Thyroid carcinoma | NA | BeFree | Detail | |
<0.001 | Chronic idiopathic urticaria | NA | BeFree | Detail | |
<0.001 | Osteosarcoma of bone | FGFR1 amplification is present disproportionately in the rarer histological vari... | BeFree | 24861215 | Detail |
0.002 | Carcinogenesis | NA | BeFree | Detail | |
<0.001 | Leukemogenesis | NA | BeFree | Detail | |
<0.001 | Lymphoid neoplasm | Myeloid and lymphoid neoplasm with abnormalities of FGFR1 presenting with trilin... | BeFree | 25873510 | Detail |
0.002 | lymphoma | It is hoped that the same will happen in other MPN with specific genetic alterat... | BeFree | 19175693 | Detail |
0.002 | prostate carcinoma | NA | BeFree | Detail | |
0.006 | breast carcinoma | NA | BeFree | Detail | |
0.004 | Carcinoma of lung | The aim of this study was to investigate the prevalence of fibroblast growth fac... | BeFree | 24762544 | Detail |
0.004 | Carcinoma of lung | FGFR1 mRNA and protein expression, not gene copy number, predict FGFR TKI sensit... | BeFree | 24771645 | Detail |
0.004 | Carcinoma of lung | FGFR1 activation is an escape mechanism in human lung cancer cells resistant to ... | BeFree | 25115383 | Detail |
0.004 | Carcinoma of lung | Kinome RNAi Screens Reveal Synergistic Targeting of MTOR and FGFR1 Pathways for ... | BeFree | 26359452 | Detail |
0.001 | Secondary malignant neoplasm of lymph node | One hundred twelve primary tumors (including squamous cell carcinoma [SCC], carc... | BeFree | 23913758 | Detail |
0.001 | Secondary malignant neoplasm of lymph node | FGFR1 amplification trends to correlate with lymph node metastasis and smoking. | BeFree | 25433983 | Detail |
<0.001 | Parathyroid Gland Adenocarcinoma | NA | BeFree | Detail | |
<0.001 | stomach carcinoma | Identification of gastric cancers harboring FGFR1 amplification may be important... | BeFree | 26239623 | Detail |
0.001 | Carcinoma of bladder | NA | BeFree | Detail | |
<0.001 | Central neuroblastoma | NA | BeFree | Detail | |
<0.001 | Congenital pes cavus | NA | BeFree | Detail | |
<0.001 | colon cancer liver metastasis | NA | BeFree | Detail | |
<0.001 | Central Core Myopathy (disorder) | Therefore, RUNX2 signaling pathways with their partners TCF7 and FGFR1/2 may not... | BeFree | 25738174 | Detail |
<0.001 | malignant pleural mesothelioma | Nonamplified FGFR1 is a growth driver in malignant pleural mesothelioma. | BeFree | 24966347 | Detail |
<0.001 | malignant pleural mesothelioma | Absence of amplification of the FGFR1-gene in human malignant mesothelioma of th... | BeFree | 25138167 | Detail |
<0.001 | impaired motor coordination | NA | BeFree | Detail | |
<0.001 | Renal ischaemia | HK-2 cells were subjected to oxygen and glucose deprivation followed by re-oxyge... | BeFree | 25766531 | Detail |
<0.001 | Thyroid hyperplasia | NA | BeFree | Detail | |
<0.001 | Malignant neoplasm of ovary | Both epidermal growth factor receptor (EGFR) and fibroblast growth factor recept... | BeFree | 25919378 | Detail |
<0.001 | Squamous cell carcinoma of the head and neck | NA | BeFree | Detail | |
<0.001 | sarcoma | Canine and human sarcomas exhibit predominant FGFR1 expression and impaired viab... | BeFree | 24719266 | Detail |
<0.001 | Nonseminomatous germ cell tumor | NA | BeFree | Detail | |
<0.001 | major depressive disorder | NA | BeFree | Detail | |
0.001 | Precursor T-cell lymphoblastic lymphoma | NA | BeFree | Detail | |
<0.001 | Precursor B-cell lymphoblastic leukemia | NA | BeFree | Detail | |
0.007 | Chronic myeloproliferative disorder | NA | BeFree | Detail | |
<0.001 | Precursor T cell lymphoblastic leukemia/lymphoblastic lymphoma | NA | BeFree | Detail | |
0.002 | Eosinophilic disorder | NA | BeFree | Detail | |
<0.001 | pancreatic ductal adenocarcinoma | NA | BeFree | Detail | |
<0.001 | Refractory Neoplasm | NA | BeFree | Detail | |
<0.001 | thalamic neoplasm | NA | BeFree | Detail | |
0.002 | Plagiocephaly, Nonsynostotic | NA | GAD | Detail | |
0.127 | Mammary Neoplasms | NA | BeFree,CTD_human,LHGDN | Detail | |
0.002 | acrocephalosyndactylia | NA | GAD | Detail | |
<0.001 | Angiogenic Switch | NA | BeFree | Detail | |
<0.001 | Hepatocarcinogenesis | NA | BeFree | Detail | |
<0.001 | Mammary Tumorigenesis | NA | BeFree | Detail | |
<0.001 | Tumor Angiogenesis | NA | BeFree | Detail | |
<0.001 | Xenograft Model | NA | BeFree | Detail | |
0.001 | colorectal cancer | Finally we found that cells overexpressing SOX2 in vitro showed enhanced express... | BeFree | 25010701 | Detail |
0.001 | colorectal cancer | AZD-4547 was cytotoxic and pro-apoptotic in FGFR-1/2-expressed CRC cell lines (N... | BeFree | 25691251 | Detail |
<0.001 | hypereosinophilic syndrome | NA | BeFree | Detail | |
<0.001 | Chronic Kidney Diseases | NA | BeFree | Detail | |
<0.001 | Kallmann Syndrome 1 | NA | BeFree | Detail | |
<0.001 | RENAL ADYSPLASIA | NA | BeFree | Detail | |
<0.001 | Glioblastoma multiforme | NA | BeFree | Detail | |
0.002 | Disorder characterized by eosinophilia | NA | BeFree | Detail | |
<0.001 | Benign Prostatic Hyperplasia | NA | BeFree | Detail | |
<0.001 | Hyperparathyroidism-Jaw Tumor Syndrome | NA | BeFree | Detail | |
<0.001 | Meningioma, benign, no ICD-O subtype | NA | BeFree | Detail | |
0.080 | OTITIS MEDIA, SUSCEPTIBILITY TO (finding) | NA | MGD | Detail | |
0.361 | Holoprosencephaly, Ectrodactyly, and Bilateral Cleft Lip/Palate | Novel de novo heterozygous FGFR1 mutation in two siblings with Hartsfield syndro... | BeFree,CLINVAR,ORPHANET,UNIPROT | 24888332 | Detail |
<0.001 | HYPERTRICHOSIS, CONGENITAL GENERALIZED | NA | BeFree | Detail | |
<0.001 | campomelic dysplasia | NA | BeFree | Detail | |
<0.001 | Inverted Squamous Cell Papilloma | FGFR1 amplification was found in subsets of sinonasal SCCs (20%), carcinomas ass... | BeFree | 23913758 | Detail |
<0.001 | Precursor T-Cell Lymphoblastic Leukemia-Lymphoma | NA | BeFree | Detail | |
0.001 | Precursor Cell Lymphoblastic Leukemia Lymphoma | NA | BeFree | Detail | |
<0.001 | low grade glioma | Pediatric LGG show alterations in FGFR1 and BRAF in pilocytic astrocytomas and F... | BeFree | 25664944 | Detail |
<0.001 | Urothelial Carcinoma | NA | BeFree | Detail | |
<0.001 | liver carcinoma | NA | BeFree | Detail | |
<0.001 | Allergic rhinitis (disorder) | NA | BeFree | Detail | |
<0.001 | Metastatic Lobular Breast Carcinoma | NA | BeFree | Detail | |
<0.001 | Split-Hand/Foot Malformation | NA | BeFree | Detail | |
<0.001 | Placental Steroid Sulfatase Deficiency | NA | BeFree | Detail | |
0.007 | Myeloid and Lymphoid Neoplasms with FGFR1 Rearrangement | NA | BeFree | Detail | |
<0.001 | Split hand foot deformity 1 | NA | BeFree | Detail | |
0.120 | Pfeiffer type acrocephalosyndactyly | NA | CTD_human | Detail | |
0.080 | Neointima | NA | RGD | Detail | |
0.120 | Antley-Bixler Syndrome, Autosomal Dominant | NA | CTD_human | Detail | |
0.122 | CHROMOSOME 8p11 MYELOPROLIFERATIVE SYNDROME | NA | BeFree,ORPHANET | Detail | |
<0.001 | Triple Negative Breast Neoplasms | Expression of FGFR1 is an independent prognostic factor in triple-negative breas... | BeFree | 25868865 | Detail |
<0.001 | Allergic disposition | Prediction of food allergy improved when FLG LOF variants were included in the m... | BeFree | 25620092 | Detail |
<0.001 | Phosphaturic mesenchymal tumor, benign | Identification of a novel FN1-FGFR1 genetic fusion as a frequent event in phosph... | BeFree | 25319834 | Detail |
<0.001 | Congenital Abnormality | NA | BeFree | Detail | |
<0.001 | acanthosis nigricans | NA | BeFree | Detail | |
<0.001 | Apert syndrome | NA | BeFree | Detail | |
<0.001 | acute pancreatitis | NA | BeFree | Detail | |
0.006 | adenocarcinoma | In resected tumors, 22% of adenocarcinomas and 28% of SCCs expressed high FGFR1 ... | BeFree,LHGDN | 24771645 | Detail |
0.002 | Alzheimer's disease | NA | GAD | Detail | |
<0.001 | ameloblastoma | NA | BeFree | Detail | |
0.002 | amenorrhea | NA | GAD | Detail | |
<0.001 | Anaplasia | NA | BeFree | Detail | |
0.002 | Anosmia | NA | BeFree | Detail | |
<0.001 | arteriosclerosis | Here, we investigated the role played by endothelial-to-mesenchymal transition (... | BeFree | 26517696 | Detail |
<0.001 | rheumatoid arthritis | NA | BeFree | Detail | |
0.002 | asthma | NA | BeFree | Detail | |
0.121 | Astrocytoma | NA | BeFree,CTD_human | Detail | |
<0.001 | atherosclerosis | Here, we investigated the role played by endothelial-to-mesenchymal transition (... | BeFree | 26517696 | Detail |
0.001 | Malignant neoplasm of urinary bladder | NA | BeFree | Detail | |
0.003 | Bladder Neoplasm | NA | LHGDN | Detail | |
<0.001 | Brain Neoplasms | NA | BeFree | Detail | |
0.008 | Malignant neoplasm of breast | NA | BeFree,GAD | Detail | |
<0.001 | Adenocarcinoma of prostate | NA | BeFree | Detail | |
<0.001 | Malignant neoplasm of thyroid | NA | BeFree | Detail | |
<0.001 | Bronchioloalveolar Adenocarcinoma | NA | BeFree | Detail | |
0.124 | Non-small cell lung carcinoma | Increased SOX2 gene copy number is associated with FGFR1 and PIK3CA gene gain in... | BeFree,CTD_human | 24736592 | Detail |
0.124 | Non-small cell lung carcinoma | FGFR1/3 tyrosine kinase fusions define a unique molecular subtype of non-small c... | BeFree,CTD_human | 24850843 | Detail |
0.124 | Non-small cell lung carcinoma | Although FGFR1 amplification is rare in SCLC compared to non-small cell lung can... | BeFree,CTD_human | 25819384 | Detail |
Annotation
Annotations
Descrption | Source | Links |
---|---|---|
One hundred twelve primary tumors (including squamous cell carcinoma [SCC], carcinoma associated wit... | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
In the present study, we found that bFGF induced VEGF (vascular endothelial growth factor) expressio... | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
Expression of RUNX2 and its signaling partners TCF7, FGFR1/2 in cleidocranial dysplasia. | DisGeNET | Detail |
Finally we found that cells overexpressing SOX2 in vitro showed enhanced expression of FGFR1, which ... | DisGeNET | Detail |
AZD-4547 was cytotoxic and pro-apoptotic in FGFR-1/2-expressed CRC cell lines (NCI-H716 and HCT-116)... | DisGeNET | Detail |
NA | DisGeNET | Detail |
The extent of coronary atherosclerosis in this patient set strongly correlated with loss of endothel... | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
FLG mutations affected the lifetime prevalence of hand and foot dermatitis in participants with a hi... | DisGeNET | Detail |
Patients (n = 43) were classified according to their FLG status: AD with FLG+/+ (n = 14), AD with FL... | DisGeNET | Detail |
FLG mutations affected the lifetime prevalence of hand and foot dermatitis in participants with a hi... | DisGeNET | Detail |
NA | DisGeNET | Detail |
Patients (n = 43) were classified according to their FLG status: AD with FLG+/+ (n = 14), AD with FL... | DisGeNET | Detail |
FLG deficiency predisposes to eczema vaccinatum. | DisGeNET | Detail |
FLG mutations affected the lifetime prevalence of hand and foot dermatitis in participants with a hi... | DisGeNET | Detail |
Increased expression of fibroblast growth factor receptor 1 in endometriosis and its correlation wit... | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
A Functional Role of Fibroblast Growth Factor Receptor 1 (FGFR1) in the Suppression of Influenza A V... | DisGeNET | Detail |
A female patient with normosmic idiopathic hypogonadotropic hypogonadism carrying a novel mutation i... | DisGeNET | Detail |
Novel FGFR1 mutations in Kallmann syndrome and normosmic idiopathic hypogonadotropic hypogonadism: e... | DisGeNET | Detail |
NA | DisGeNET | Detail |
Interestingly, unlike the prototypical leukaemia-inducing FGFR1 fusion genes, which are ligand-indep... | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
A tissue microarray composed of resected lung tumors was submitted to FGFR1 GCN, and mRNA analyses a... | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
Identification of gastric cancers harboring FGFR1 amplification may be important in preselecting pat... | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
Furthermore, RNAi-mediated silencing confirmed the requirement for FGFR1 in specific mesothelioma ce... | DisGeNET | Detail |
The aim of this study was to evaluate the amplification of the FGFR1 gene in patients suffering from... | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
Amplification of the FGFR1 gene is a rare but noticeable event that can be found in 2% (6/293) of ca... | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
Compared to Hyp mice, compound Hyp;Fgfr1Dmp1-cKO-null mice had significant improvement in rickets an... | DisGeNET | Detail |
FGFR1 amplification is present disproportionately in the rarer histological variants of osteosarcoma... | DisGeNET | Detail |
Both epidermal growth factor receptor (EGFR) and fibroblast growth factor receptor 1 (FGFR1) are ove... | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
Compared to Hyp mice, compound Hyp;Fgfr1Dmp1-cKO-null mice had significant improvement in rickets an... | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
Here, we investigated four members of the fibroblast growth factor receptor (FGFR) family; FGFR1 to ... | DisGeNET | Detail |
NA | DisGeNET | Detail |
Moisturizing treatment of patients with atopic dermatitis and ichthyosis vulgaris improves dry skin,... | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
The purpose of this study was to elucidate if these tumors harbor amplifications of the fibroblast g... | DisGeNET | Detail |
Importantly, only 46% of SCCs with increased FGFR1 GCN expressed high mRNA. | DisGeNET | Detail |
FGFR1 amplification in lung squamous cell carcinoma: a systematic review with meta-analysis. | DisGeNET | Detail |
The frequency and impact of FGFR1 amplification on clinical outcomes in Korean patients with small c... | DisGeNET | Detail |
NA | DisGeNET | Detail |
Moisturizing treatment of patients with atopic dermatitis and ichthyosis vulgaris improves dry skin,... | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
Prostate cancer cell-stromal cell crosstalk via FGFR1 mediates antitumor activity of dovitinib in bo... | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
TGFβ, FGA, PDGFc, PDGFRa, FGF, FGFR1, FGFR2 growth factors as well as MMP and TIMP2 proteolytic enzy... | DisGeNET | Detail |
Childhood growth of females with Kallmann syndrome and FGFR1 mutations. | DisGeNET | Detail |
Mutations in the fibroblast growth factor receptor 1 gene (FGFR1) have been reported in patients wit... | DisGeNET | Detail |
Novel FGFR1 mutations in Kallmann syndrome and normosmic idiopathic hypogonadotropic hypogonadism: e... | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
FGFR1 amplification was found in subsets of sinonasal SCCs (20%), carcinomas associated with an inve... | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
Here, we report that ligands from the FGF family reduced the effectiveness of imatinib in GIST cells... | DisGeNET | Detail |
NA | DisGeNET | Detail |
The aim of this study was to investigate the prevalence of fibroblast growth factor receptor 1 (FGFR... | DisGeNET | Detail |
FGFR1 mRNA and protein expression, not gene copy number, predict FGFR TKI sensitivity across all lun... | DisGeNET | Detail |
FGFR1 activation is an escape mechanism in human lung cancer cells resistant to afatinib, a pan-EGFR... | DisGeNET | Detail |
Kinome RNAi Screens Reveal Synergistic Targeting of MTOR and FGFR1 Pathways for Treatment of Lung Ca... | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
A female patient with normosmic idiopathic hypogonadotropic hypogonadism carrying a novel mutation i... | DisGeNET | Detail |
Novel FGFR1 mutations in Kallmann syndrome and normosmic idiopathic hypogonadotropic hypogonadism: e... | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
Fibroblast growth factor receptor 1 gene amplification in gastric adenocarcinoma. | DisGeNET | Detail |
NA | DisGeNET | Detail |
Fibroblast growth factor receptor 1 gene amplification is associated with poor survival in patients ... | DisGeNET | Detail |
The FGFR1 is a therapeutic target under investigation in multiple solid tumors and clinical trials o... | DisGeNET | Detail |
NA | DisGeNET | Detail |
Pediatric LGG show alterations in FGFR1 and BRAF in pilocytic astrocytomas and FGFR1 alterations in ... | DisGeNET | Detail |
NA | DisGeNET | Detail |
Pediatric LGG show alterations in FGFR1 and BRAF in pilocytic astrocytomas and FGFR1 alterations in ... | DisGeNET | Detail |
KIAA1549: BRAF Gene Fusion and FGFR1 Hotspot Mutations Are Prognostic Factors in Pilocytic Astrocyto... | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
Finally we found that cells overexpressing SOX2 in vitro showed enhanced expression of FGFR1, which ... | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
FGFR1 amplification is present disproportionately in the rarer histological variants of osteosarcoma... | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
Myeloid and lymphoid neoplasm with abnormalities of FGFR1 presenting with trilineage blasts and RUNX... | DisGeNET | Detail |
It is hoped that the same will happen in other MPN with specific genetic alterations: polycythemia v... | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
The aim of this study was to investigate the prevalence of fibroblast growth factor receptor 1 (FGFR... | DisGeNET | Detail |
FGFR1 mRNA and protein expression, not gene copy number, predict FGFR TKI sensitivity across all lun... | DisGeNET | Detail |
FGFR1 activation is an escape mechanism in human lung cancer cells resistant to afatinib, a pan-EGFR... | DisGeNET | Detail |
Kinome RNAi Screens Reveal Synergistic Targeting of MTOR and FGFR1 Pathways for Treatment of Lung Ca... | DisGeNET | Detail |
One hundred twelve primary tumors (including squamous cell carcinoma [SCC], carcinoma associated wit... | DisGeNET | Detail |
FGFR1 amplification trends to correlate with lymph node metastasis and smoking. | DisGeNET | Detail |
NA | DisGeNET | Detail |
Identification of gastric cancers harboring FGFR1 amplification may be important in preselecting pat... | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
Therefore, RUNX2 signaling pathways with their partners TCF7 and FGFR1/2 may not be involved in CCD ... | DisGeNET | Detail |
Nonamplified FGFR1 is a growth driver in malignant pleural mesothelioma. | DisGeNET | Detail |
Absence of amplification of the FGFR1-gene in human malignant mesothelioma of the pleura: a pilot st... | DisGeNET | Detail |
NA | DisGeNET | Detail |
HK-2 cells were subjected to oxygen and glucose deprivation followed by re-oxygenation (OGD/R) to mi... | DisGeNET | Detail |
NA | DisGeNET | Detail |
Both epidermal growth factor receptor (EGFR) and fibroblast growth factor receptor 1 (FGFR1) are ove... | DisGeNET | Detail |
NA | DisGeNET | Detail |
Canine and human sarcomas exhibit predominant FGFR1 expression and impaired viability after inhibiti... | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
Finally we found that cells overexpressing SOX2 in vitro showed enhanced expression of FGFR1, which ... | DisGeNET | Detail |
AZD-4547 was cytotoxic and pro-apoptotic in FGFR-1/2-expressed CRC cell lines (NCI-H716 and HCT-116)... | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
Novel de novo heterozygous FGFR1 mutation in two siblings with Hartsfield syndrome: a case of gonada... | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
FGFR1 amplification was found in subsets of sinonasal SCCs (20%), carcinomas associated with an inve... | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
Pediatric LGG show alterations in FGFR1 and BRAF in pilocytic astrocytomas and FGFR1 alterations in ... | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
Expression of FGFR1 is an independent prognostic factor in triple-negative breast cancer. | DisGeNET | Detail |
Prediction of food allergy improved when FLG LOF variants were included in the model. | DisGeNET | Detail |
Identification of a novel FN1-FGFR1 genetic fusion as a frequent event in phosphaturic mesenchymal t... | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
In resected tumors, 22% of adenocarcinomas and 28% of SCCs expressed high FGFR1 mRNA. | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
Here, we investigated the role played by endothelial-to-mesenchymal transition (EndMT) and its key r... | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
Here, we investigated the role played by endothelial-to-mesenchymal transition (EndMT) and its key r... | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
Increased SOX2 gene copy number is associated with FGFR1 and PIK3CA gene gain in non-small cell lung... | DisGeNET | Detail |
FGFR1/3 tyrosine kinase fusions define a unique molecular subtype of non-small cell lung cancer. | DisGeNET | Detail |
Although FGFR1 amplification is rare in SCLC compared to non-small cell lung cancer or other maligna... | DisGeNET | Detail |
Overlapped Transcript Coordinates
Gene | Transcript ID | Exon Number | Chromosome | Start | Stop | Type | Amino Mutation | Transcript Position | Links |
---|
Overlapped Transcript
Gene | Transcript ID | Chromosome | Start | Stop | Links |
---|
- Gene
- -
- dbSNP
- rs386626619 dbSNP
- Genome
- hg19
- Position
- chr8:38,268,656-38,326,352
- Variant Type
- snv
- Variant (CIViC) (CIViC Variant)
- MUTATION
- Variant URL (CIViC Variant)
- https://civic.genome.wustl.edu/links/variants/2641
Genome browser